Get an alert when CELL THERAPY CATAPULT LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-12-31 (in 7mo)

Last filed for 2025-03-31

Confirmation statement due

2027-04-14 (in 11mo)

Last made up 2026-03-31

Watchouts

None on the register

Cash

£38M

+5.7% vs 2024

Net assets

£69M

-7.3% vs 2024

Employees

403

-0.7% vs 2024

Profit before tax

-£7M

-12.6% vs 2024

Accounts

2-year trend · latest reflected 2025-03-31

Metric Trend 2024-03-312025-03-31
Turnover £53,525,000£52,861,000
Operating profit -£7,127,000-£8,394,000
Profit before tax -£6,497,000-£7,316,000
Net profit -£6,809,000-£5,383,000
Cash £35,755,000£37,809,000
Total assets less current liabilities £112,510,000£94,891,000
Net assets £74,204,000£68,821,000
Equity £74,204,000£68,821,000
Average employees 406403
Wages £23,964,000£24,145,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2024-03-312025-03-31
Operating margin -13.3%-15.9%
Net margin -12.7%-10.2%
Return on capital employed -6.3%-8.8%
Current ratio 2.63x1.73x
Interest cover -192.62x-270.77x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
Cooper Parry Group Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors have prepared the financial statements on a going concern basis which they consider to be appropriate, citing a grant funding agreement with Innovate UK for core funds until March 2028, and a further Innovation Grant until March 2027. Forecasts indicate current cash reserves are sufficient to meet liabilities for at least 12 months.”

Group structure

  1. CELL THERAPY CATAPULT LIMITED · parent
    1. Cell Therapy Catapult Services Limited 100% · UK · Commercial research and collaboration services
    2. CGTC Manufacturing Innovation Centre Ltd 100% · UK · Commercial research and collaboration services
    3. Cell and Gene Therapy Catapult 100% · UK · Dormant

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

12 active · 20 resigned

Name Role Appointed Born Nationality
BARRY, Jacqueline Anne Director 2017-02-04 Jun 1965 British
CHATFIELD, Steven Neville, Dr Director 2016-01-01 Jan 1957 British
DURDY, Matthew Brian Director 2016-01-01 Jun 1966 British
FAULKNER, Jim Director 2024-04-25 May 1965 British
GRIESENBACH, Uta, Professor Director 2018-09-01 Jan 1964 German
KEOGH, Bruce Edward, Professor Sir Director 2018-09-01 Nov 1954 British
LOKE, Hsin, Dr Director 2024-09-01 Sep 1972 Malaysian
MATHER, Nicole, Dr Director 2024-04-25 Aug 1974 British
NEWISS, Hilary Jane Director 2018-09-01 Apr 1956 British
PORTER, Carolyn, Dr Director 2024-04-25 Jul 1970 British
THOMAS, Angela Eleine, Prof. Director 2020-10-13 Jun 1957 British
WARD, Stephen, Dr Director 2016-01-01 Jun 1970 British
Show 20 resigned officers
Name Role Appointed Resigned
CROSSLEY, Simon Secretary 2014-03-20 2022-08-19
STAIT, Christopher Martin Secretary 2012-04-25 2013-12-11
BROWN, John Robert, Dr Director 2012-10-13 2022-02-01
BRYAN, Robert Kenneth Director 2012-04-16 2013-02-21
CAMPBELL, Ian William, Dr Director 2021-01-25 2024-03-31
EDWARDS, Timothy Peter Warren Director 2013-01-24 2015-10-14
FODEN, Susan Elizabeth Director 2016-01-01 2017-10-12
GARNETT, Margaret Anne Director 2012-02-24 2012-04-16
HENDERSON, Stuart Jonathon Brodie Director 2016-06-01 2022-08-01
HIGGINS, Nicolas Andrew Director 2013-01-24 2021-06-01
HUTCHINS, John Richard Graham Director 2012-05-10 2013-01-24
HYLLNER, Sven Johan, Professor Director 2016-01-01 2018-05-23
LATIF, Zahid, Dr Director 2012-10-04 2015-12-09
MCCUBBIN, Ian Director 2022-02-01 2025-07-31
MOUNT, Natalie Marianne, Dr Director 2016-01-01 2017-02-04
SODEN, Christine Helen Director 2020-10-13 2024-07-31
THOMPSON, Keith John Director 2012-09-19 2020-03-31
TURNER, Marc Leighton, Professor Director 2013-01-24 2021-03-31
WATT, Fiona Mary, Dr Director 2016-01-01 2018-03-21
WHITAKER, Michael John, Professor Director 2013-01-24 2019-05-31

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Mr Matthew Brian Durdy Individual Voting 25–50% 2020-04-02 Ceased 2021-03-02
Dr John Robert Brown Individual Voting 25–50% 2016-04-06 Ceased 2021-03-02
Mr Keith John Thompson Individual Voting 25–50% 2016-04-06 Ceased 2020-04-02

Filing timeline

Last 20 of 105 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2024-09-18 RESOLUTIONS Resolution
  • 2024-05-15 RESOLUTIONS Resolution
  • 2024-05-15 RESOLUTIONS Resolution
Date Type Category Description
2026-04-15 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-04-15 AD02 address Change sail address company with old address new address PDF
2025-12-05 AA accounts Accounts with accounts type group
2025-07-31 TM01 officers Termination director company with name termination date PDF
2025-03-31 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-03-06 CH01 officers Change person director company with change date PDF
2024-09-18 RESOLUTIONS resolution Resolution
2024-09-11 AA accounts Accounts with accounts type group
2024-09-02 AP01 officers Appoint person director company with name date PDF
2024-08-01 TM01 officers Termination director company with name termination date PDF
2024-05-15 RESOLUTIONS resolution Resolution
2024-05-15 RESOLUTIONS resolution Resolution
2024-05-09 RP04AP01 officers Second filing of director appointment with name PDF
2024-05-02 AP01 officers Appoint person director company with name date PDF
2024-05-02 AP01 officers Appoint person director company with name date
2024-05-02 AP01 officers Appoint person director company with name date PDF
2024-05-02 TM01 officers Termination director company with name termination date PDF
2024-04-05 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-09-04 AA accounts Accounts with accounts type group
2023-04-13 CS01 confirmation-statement Confirmation statement with no updates PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-03-31 vs 2024-03-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page